MedTrace Logo

Descriptive, Prospective, Non-interventional Study (NIS) to Describe Mirena and Amenorrhea Related Acceptability in Contraception Indication in Medical Practice

NCT01833793 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2015-09-14

No results posted yet for this study

Summary

MARILIA is a prospective, non-interventional, multicenter study. The purpose of this study is to describe the acceptability of Amenorrhea in contraception indication of Mirena users during one year follow up in medical practice. 500 patients in 20 centers will be enrolled in the study. Bleeding profile, removal or non-removal of the IUS (IntraUterine System) will be evaluated.

Conditions

  • Female Contraception

Interventions

DRUG

Levonorgestrel IUD (Mirena, BAY86-5028)

Women who have been prescribed Mirena in contraception; followed up for 12 months

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2014-11-30
Completion
2015-05-31

Countries

  • Algeria

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01833793 on ClinicalTrials.gov